12/23
07:27 am
meso
Mesoblast Limited (NASDAQ: MESO) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.
High
Report
Mesoblast Limited (NASDAQ: MESO) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.
12/20
06:12 am
meso
ISCT Hails Landmark US FDA Approval of RYONCIL as Major Milestone for MSC Field [Yahoo! Finance]
Medium
Report
ISCT Hails Landmark US FDA Approval of RYONCIL as Major Milestone for MSC Field [Yahoo! Finance]
12/19
12:57 pm
meso
Mesoblast Limited (NASDAQ: MESO) had its price target raised by analysts at Piper Sandler from $11.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
Mesoblast Limited (NASDAQ: MESO) had its price target raised by analysts at Piper Sandler from $11.00 to $15.00. They now have an "overweight" rating on the stock.
12/19
08:07 am
meso
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease [Yahoo! Finance]
Medium
Report
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease [Yahoo! Finance]
12/19
06:43 am
meso
How has the FDA approval of Ryoncil affected Mesoblast's stock price? [Yahoo! Finance]
Medium
Report
How has the FDA approval of Ryoncil affected Mesoblast's stock price? [Yahoo! Finance]
12/18
07:08 pm
meso
Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
Low
Report
Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
12/18
07:30 am
meso
Mesoblast to be Added to Nasdaq Biotechnology Index
Low
Report
Mesoblast to be Added to Nasdaq Biotechnology Index
12/9
12:18 pm
meso
3 ASX Growth Companies With Insider Ownership Up To 38% [Yahoo! Finance]
Low
Report
3 ASX Growth Companies With Insider Ownership Up To 38% [Yahoo! Finance]
12/4
11:39 pm
meso
Exploring High Growth Tech Stocks in Australia December 2024 [Yahoo! Finance]
Neutral
Report
Exploring High Growth Tech Stocks in Australia December 2024 [Yahoo! Finance]
12/4
06:35 pm
meso
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease [Yahoo! Finance]
High
Report
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease [Yahoo! Finance]
12/4
06:32 pm
meso
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
Medium
Report
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
12/2
06:25 pm
meso
Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation [Yahoo! Finance]
Low
Report
Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation [Yahoo! Finance]
12/2
06:20 pm
meso
Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation
Low
Report
Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation
11/28
05:04 pm
meso
Mesoblast Limited's (ASX:MSB) 17% gain last week benefited both retail investors who own 54% as well as insiders [Yahoo! Finance]
Low
Report
Mesoblast Limited's (ASX:MSB) 17% gain last week benefited both retail investors who own 54% as well as insiders [Yahoo! Finance]
11/18
08:42 am
meso
Stem Cell Therapy Market Expected To Reach 31.33 Billion, Growing at 11.20% CAGR By 2032 | Introspective Market Research [Yahoo! Finance]
Medium
Report
Stem Cell Therapy Market Expected To Reach 31.33 Billion, Growing at 11.20% CAGR By 2032 | Introspective Market Research [Yahoo! Finance]
11/7
11:11 pm
meso
ASX Growth Companies With High Insider Ownership Seeing Up To 61% Earnings Growth [Yahoo! Finance]
Low
Report
ASX Growth Companies With High Insider Ownership Seeing Up To 61% Earnings Growth [Yahoo! Finance]
10/30
07:16 pm
meso
Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024 [Yahoo! Finance]
Medium
Report
Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024 [Yahoo! Finance]
10/30
07:11 pm
meso
Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024
Medium
Report
Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024